Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
|---|---|---|---|---|---|---|
| 1 | ANAVEX2-73 | - | - | - | - | [2] 6 6, 156 |
| 2 | ANAVEX2-73 (blarcamesine) | [1] Blarcamesine Blarcamesine | [1] D11383
D11383
| [6] CHRM1 CHRM1,CHRM2, CHRM3, CHRM4, CHRM5, SIGMAR1 💬 | [14] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | [1] 156 156 |
| 3 | ANAVEX2-73 oral liquid | - | - | - | - | [1] 156 156 |
| 4 | High dose ANAVEX2-73 | - | - | - | - | [1] 6 6 |
| 5 | Mid dose ANAVEX2-73 | - | - | - | - | [1] 6 6 |